Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

<ul><li>CVS Health Corporation's first quarter results were an all-around beat as the company performed well in terms of revenue growth, operating cash flow, and adjusted profits per share.</li><li>Revenues for the first quarter of $85.3 billion were up 11% year over year, demonstrating significant growth in all of their businesses.</li><li>However, the company anticipates decreases for the remainder of the year as the public health emergency ends.</li></ul>

CVS Health Corporation's first quarter results were an all-around beat as the company performed well in terms of revenue growth, operating cash flow, and adjusted profits per share.Revenues for the first quarter of $85.3 billion were up 11% year over year, demonstrating significant growth in all of their businesses.However, the company anticipates decreases for the remainder of the year as the public health emergency ends.

CVS Health Corporation: Does The Signify Acquisition Make It A Sureshot Buy? – Key Drivers

Cvs Health Corp

CVS Health Corporation: Does The Signify Acquisition Make It A Sureshot Buy? – Key Drivers